Search results
Results from the WOW.Com Content Network
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows ...
Dana–Farber Cancer Institute; Whitehead Institute for Biomedical Research (Massachusetts Institute of Technology) Missouri. McDonnell Genome Institute (Washington University in St. Louis) New Mexico. National Center for Genome Resources; New York. Cold Spring Harbor Laboratory; Icahn Institute for Genomics and Multiscale Biology (Icahn School ...
The center was established in 1978 and received its NCI designation the same year. It earned comprehensive status in 2001. [1] There are approximately 360 faculty members affiliated with the center. A five-story building, home to the center, was opened in La Jolla in 2005. [2] The Moores Cancer Center provides outpatient treatment on site.
He is the co-founder and executive chairman of Natera (NTRA), a clinical genetic testing company. He serves as executive chairman, board member, adviser and angel investor to several companies and non-profits in diagnostics , biotech , machine learning , health services and nature conservation.
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease.
Color Data, a database containing aggregated genetic and clinical information from 50,000 individuals who took a Color test, [26] helps researchers and scientists identify genotype-phenotype correlations and novel variants for functional analysis, as well as enables data-driven drug discovery and development. It is the largest public database ...
Guardant Health said the test would be the "first and only comprehensive biopsy-free cancer test available". [7] In 2016, the company announced clinical trial results demonstrating the test "detected disease-associated genetic mutations that were also present in 94% to 100% of the solid tissues extracted from the study's subjects". [8]
The USC Norris Comprehensive Cancer Center is a cancer center in Los Angeles, California owned and operated by the University of Southern California (USC) through its Keck School of Medicine. It was one of the first eight comprehensive cancer centers in the United States, which is devoted to patient care, prevention, research, and education.